Research, Brokerage & Sentiment › Sub-category
Conference Call Takeaway
2 articles
Vaish Unveils Low‑Cost Cirrhosis Tool, 250k Deaths
Global liver disease burden is rising, with about 250,000 annual deaths in India, highlighting a critical public‑health crisis.
Dr. Udit Bhaskar Vaish proposes using NLR and APRI indices from routine
KSB Limited CY2025 Institutional Investor Meet Transcript
KSB Limited reported CY2025 revenue of ₹26,957 million, EBITDA of ₹387 Cr, and PAT CAGR of 22% YoY.
Nuclear order book at ₹12,816 million; Tarapur RCP test bed commenced testing on March 22, 2026.
Sol